CBPO Holdings Limited completed its acquisition of China Biologic Products Holdings for $4.76 billion, or $120 per share. China Biologic Products became a private company and its shares are no longer traded on NASDAQ.
CBPO Holdings Limited completed its acquisition of China Biologic Products Holdings for $4.76 billion, or $120 per share. China Biologic Products became a private company and its shares are no longer traded on NASDAQ. 
chinabiologic.investorroom.com
English (US) 